Rani Therapeutics Inc. (RANI)

1.46

-0.07 (-4.58%)

At close: Mar 03, 2025, 3:59 PM

1.55

6.16%

After-hours: Mar 03, 2025, 07:00 PM EST

Rani Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Net Income	-33.97M	-63.34M	-53.09M	-16.7M	-26.59M
Depreciation & Amortization	822K	548K	497K	589K	564K
Stock-Based Compensation	19.01M	15.78M	22.59M	n/a	n/a
Other Working Capital	-1.54M	346K	-3.97M	111K	108K
Other Non-Cash Items	-34.96M	-10K	109K	110K	-81K
Deferred Income Tax	n/a	n/a	1.07M	n/a	n/a
Change in Working Capital	-2.14M	509K	-3.43M	1.04M	-163K
Operating Cash Flow	-51.24M	-46.52M	-32.24M	-14.96M	-26.27M
Capital Expenditures	-1.23M	-1.62M	-506K	-1.2M	-1.58M
Acquisitions	n/a	-851K	n/a	n/a	49K
Purchase of Investments	-73.26M	-73.82M	n/a	n/a	n/a
Sales Maturities Of Investments	104.35M	3M	n/a	n/a	n/a
Other Investing Acitivies	n/a	851K	n/a	n/a	49.00
Investing Cash Flow	29.86M	-72.44M	-506K	-1.2M	-1.53M
Debt Repayment	n/a	29.57M	-2.85M	4.19M	n/a
Common Stock Repurchased	-162	-626	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	233K	-569K	86.31M	68.49M	852K
Financial Cash Flow	233K	29M	77.15M	72.68M	852K
Net Cash Flow	-21.14M	-89.95M	44.4M	56.52M	-26.95M
Free Cash Flow	-52.47M	-48.13M	-32.75M	-16.16M	-27.85M